PACIRA BIOSCIENCES INC (PCRX)

US6951271005 - Common Stock

25.9  -0.91 (-3.39%)

After market: 25.9 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
541.5M
26.05%
666.8M
23.14%
674.978M
1.23%
706.17M
4.62%
EBITDA
YoY % growth
161.3M
100.62%
162.4M
0.68%
162.897M
0.31%
223.87M
37.43%
N/AN/AN/A
EBIT
YoY % growth
132.8M
119.50%
70.9M
-46.61%
87.323M
23.16%
194.98M
123.29%
Operating Margin
24.52%10.63%12.94%27.61%
EPS
YoY % growth
2.99
35.91%
2.59
-13.38%
2.92
12.74%
2.84
-2.82%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.67
26.08%
Revenue
Q2Q % growth
169.23M
5.57%
EBITDA
Q2Q % growth
46.941M
EBIT
Q2Q % growth
44.472M
394.13%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
0.89
11.25%
0.90-0.01-1.23%
Q3 2023
Q2Q % growth
0.72
12.50%
0.80-0.08-9.96%
Q2 2023
Q2Q % growth
0.78
52.94%
0.770.010.88%
Q1 2023
Q2Q % growth
0.53
-17.19%
0.63-0.10-15.78%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
181.244M
5.37%
185.3M-4.056M-2.19%
Q3 2023
Q2Q % growth
163.9M
-2.15%
175.06M-11.16M-6.37%
Q2 2023
Q2Q % growth
169.5M
0.06%
178.1M-8.6M-4.83%
Q1 2023
Q2Q % growth
160.3M
1.46%
162.02M-1.72M-1.06%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -14.46% -6.71% -19.21%
Revenue0% -3.53% -0.04% -5.13%